In vivo modulation of striatal phosphoproteins by dopaminergic agents
- 17 October 1989
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 172 (4-5) , 321-328
- https://doi.org/10.1016/0922-4106(89)90012-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousalLife Sciences, 1985
- Protein Phosphorylation and Neuronal FunctionJournal of Neurochemistry, 1985
- Neuronal Phosphoproteins: Physiological and Clinical ImplicationsScience, 1984
- DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1Nature, 1984
- DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localizationJournal of Neuroscience, 1984
- DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleusJournal of Neuroscience, 1984
- Protein phosphorylation in the brainNature, 1983
- Protein Phosphatases: Properties and Role in Cellular RegulationScience, 1983
- The role of protein phosphorylation in neural and hormonal control of cellular activityNature, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976